HEART FAILURE, DIASTOLIC
Clinical trials for HEART FAILURE, DIASTOLIC explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE, DIASTOLIC trials appear
Sign up with your email to follow new studies for HEART FAILURE, DIASTOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart failure drug enters first human safety tests
Symptom relief Not yet recruitingThis early-stage study tests a single dose of a new drug called LY3971297 in 90 adults with heart failure (either preserved or reduced ejection fraction). The main goal is to check for side effects and see how the body handles the drug. Participants will be in the hospital for ab…
Matched conditions: HEART FAILURE, DIASTOLIC
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated May 26, 2026 02:54 UTC
-
New study explores how tirzepatide works in heart failure patients
Knowledge-focused Not yet recruitingThis study looks at how tirzepatide, a diabetes and weight-loss drug, helps people with obesity and a type of heart failure called HFpEF. Researchers will measure blood volume and body fat in 50 patients over 15 months to understand why the drug improves symptoms. The goal is to …
Matched conditions: HEART FAILURE, DIASTOLIC
Phase: PHASE4 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 26, 2026 02:56 UTC
-
Heart failure study aims to uncover hidden patient groups
Knowledge-focused Not yet recruitingThis study looks at 200 adults with a type of heart failure called HFpEF to see if they can be grouped into different categories based on their medical information. Researchers want to know if these groups have different health profiles and respond differently during an exercise …
Matched conditions: HEART FAILURE, DIASTOLIC
Sponsor: Instituto Politécnico de Leiria • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC